Medical Information Only. Consult your healthcare provider before considering clinical trial enrollment.
Heart Failure NYHA Class II clinical trials
2 of 3 indexed Heart Failure NYHA Class II trials are currently recruiting.
Corpus placement: #5,209 of 28,707 conditions by registered trial count.
3 US clinical trials · 2 currently recruiting · #5,209 of 28,707 conditions by registered trial count
Heart Failure NYHA Class II: 3 US clinical trials tracked, 2 recruiting.
Heart Failure NYHA Class II is the subject of 3 registered US clinical trials on ClinicalTrials.gov, 2 of them currently open to new participants. The most active sponsor is Abbott Medical Devices, running 1 of these trials.
Enrollment posture brief
Registry condition heart-failure-nyha-class-ii
OPEN 2 | RECR 67% | LATE 0 | EARLY 0 | RANK #5209 | SPON 1
Volume-matched condition peers
Nearest open-share peer: Acute Hypoxemic Respiratory Failure (67% recruiting · 6 trials)
Heart Failure NYHA Class II lists 2 open slots (67% of 3 indexed trials). Peers are matched on registered volume, not therapeutic-area browse lists. How peer matching works →
Key findings
What ClinicalTrials.gov does not surface for Heart Failure NYHA Class II on its own pages , computed from the registry mirror as of 2026-08-08. Each line carries its own denominator so it can be quoted as it stands.
-
Heart Failure NYHA Class II is recruiting above its size-band peers.
2 of 3 indexed trials (66.7%) are open to enrollment, against a 46.5% average across 27,806 conditions with fewer than 20 trials. The peer set uses the same ClinicalTrials.gov-derived counts as this page.
Open and recent trials
3 total, page 1 of 1
PROACTIVE-HF-2 Trial Heart Failure NYHA Class II and III
Endotronix
NCT05934487
Promoting Well-being and Health in Heart Failure
Massachusetts General Hospital
NCT04829617
Hemodynamic-GUIDEd Management of Heart Failure
Abbott Medical Devices
NCT03387813
Phase Distribution
Phase data not available
Top Sponsors
Named interventions
Most-linked intervention names on Heart Failure NYHA Class II records (sponsor-reported on ClinicalTrials.gov). Counts are trial links, not unique products.
US sites by state
Facility locations filed on Heart Failure NYHA Class II trials. A trial with sites in several states counts in each.
Source: ClinicalTrials.gov, National Library of Medicine. Data is informational only.
Related
What to do with this Heart Failure NYHA Class II page
3 registered trials, 2 currently recruiting, is a starting point for a conversation, not a diagnosis or a recommendation.
- 2 Heart Failure NYHA Class II trials are currently recruiting, check eligibility criteria before contacting a site. Browse recruiting trials
- Abbott Medical Devices sponsors the most Heart Failure NYHA Class II trials on record, review their full trial history before evaluating a specific study. See Abbott Medical Devices's trials
- Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide
Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This Heart Failure NYHA Class II condition card totals 3 registered trials; most-linked intervention CardioMEMS™ HF System; top US site state Massachusetts. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.